Background and Objectives: 1,5-Anhydroglucitol (1,5-AG) is an emerging marker in the acute assessment of glycemia. 1,5-AG has been shown to be associated with glycemic excursions and also been found to have association with microvascular complications of diabetes and atherosclerosis. This study aimed to evaluate serum 1,5-AG concentration in newly diagnosed type 2 diabetes patients and find the correlation between serum 1,5-AG concentration and blood glucose concentration. Materials and Methods: The study group consisted of 60 type 2 diabetes patients aged 35–55 years and 60 age- and sex-matched controls. 1,5-AG plasma level, HbA1c, fructosamine, and blood glucose were measured in all subjects. Data analysis was done using SPSS software. Results and Discussion: 1,5-AG levels were significantly lower in patients with diabetes mellitus when compared with the control group. 1,5-AG serum level negatively correlated with postprandial blood glucose. The linear regression analysis revealed that 1,5-AG had a linear association with postprandial blood glucose. Conclusion: Serum 1,5-AG levels significantly decreased with an increase in plasma glucose concentrations in patients with diabetes mellitus. Thus monitoring of serum 1,5-AG level may be useful for evaluating glycemic control in patients with newly diagnosed diabetes mellitus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.